Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN112707801A details a high-yield route using m-cresol. Reduces cost and complexity for pyrethroid pesticide intermediates with 99.3% purity.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Novel copper-catalyzed route offers cost reduction in pharma manufacturing. High-purity triazole derivatives available for commercial scale-up.
Novel one-pot synthesis method for cephalosporin intermediate ensuring high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Patent CN101531628B reveals a scalable one-pot hydrogenation route for 4-dimethylaminopiperidine hydrochloride, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel photocatalytic method for gamma-hydroxycarboxylic acids using CO2. Offers mild conditions and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN111170886B details a novel mild oxidation and demethylation route for dezocine impurities, ensuring high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN113480521B details a novel synthesis route for Bepotastine Besilate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN100434427C reveals efficient acid-catalyzed route. High yields, recyclable catalyst. Ideal for pharma R&D and supply chain optimization.
Patent CN111087340B reveals a novel one-step Friedel-Crafts alkylation for Vilazodone intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel acetalization method removes aldehyde impurities from progesterone, ensuring >99.5% purity and <0.2% aldehydes for pharmaceutical compliance.
Patent CN1269819C reveals a safer synthetic route for temozolomide, eliminating hazardous reagents and improving yield for cost reduction in API manufacturing.
Advanced synthetic routes for Entecavir manufacturing offering improved yield and purity. Reliable pharmaceutical intermediate supplier solutions for global supply chains.
Patent CN113801010A reveals a high-yield route for 5-bromo-2-chlorobenzoic acid, a key SGLT2 inhibitor intermediate, offering superior purity and supply chain stability.
Patent CN102603607A details a cost-effective route for (R)-Oxiracetam using ion exchange purification. Achieve >98.5% purity with scalable, eco-friendly manufacturing processes.
Patent CN102059145A details a novel copper-catalyzed asymmetric Henry reaction for producing high-purity (S)-octopamine and anticancer intermediates with improved cost efficiency.
Patent CN112121845B reveals efficient toluene oxidation. Enables cost reduction and high purity for reliable benzoic acid supply chain partners globally.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.